Peter D. Haytaian - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role: EVP & Pres Carelon & CarelonRx
Signature: /s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol: ELV
Transactions as of: Mar 1, 2023
Transactions value $: -$2,848,459
Form type: 4
Date filed: 3/3/2023, 03:17 PM
Previous filing: Nov 3, 2022
Next filing: Nov 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELV	Common Stock	Tax liability	-$285K	-607	-5.07%	$469.03	11.4K	Mar 1, 2023	Direct	F1
transaction	ELV	Common Stock	Award	$0	+2.29K	+20.19%	$0.00	13.6K	Mar 1, 2023	Direct	F2
transaction	ELV	Common Stock	Award	$0	+9.72K	+71.2%	$0.00	23.4K	Mar 1, 2023	Direct	F3
transaction	ELV	Common Stock	Tax liability	-$2.56M	-5.47K	-23.41%	$468.78	17.9K	Mar 2, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELV	Employee Stock Option (Right to Buy)	Award	$0	+8.81K		$0.00	8.81K	Mar 1, 2023	Common Stock	8.81K	$469.03	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2	Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
F3	Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
F4	The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.